Steroid resistant graft rejection

Indication for Antithymocyte immunoglobulin

Population group: Suitable for both men and women, only adults (18 years old or older)

For this indication, competent medicine agencies globally authorize below treatments:

1.5 mg/kg once daily

Route of admnistration


Defined daily dose

1.5 - 1.5 mg per kg of body weight

Dosage regimen

From 1.5 To 1.5 mg per kg of body weight once every day

Detailed description

1.5 mg/kg/day for 7 to 14 days after transplantation of a kidney, corresponding to a cumulative dose of 10.5 to 21 mg/kg.

Dosage considerations

Infuse slowly into a high-flow vein. Adjust the infusion rate so that the total duration of infusion is not less than 6 hours.

Active ingredient

Antithymocyte immunoglobulin is a selective immunosuppressive agent mostly acting on T lymphocytes. Antithymocyte immunoglobulin is used for the prevention and treatment of graft rejection after solid organ transplantation, usually in combination with other immunosuppressive drugs.

Read more about Antithymocyte immunoglobulin

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner